Regulatory Terminology Management

Regulatory terminology isn’t translation—it’s compliance infrastructure. When “Aqua” appears as “Water” in one PIF section and “Aqua” in another, CPNP systems flag inconsistencies that delay or reject submissions. When a claim uses “reduces wrinkles” where substantiation only supports “visibly reduces the appearance of wrinkles,” the submission triggers regulatory queries. Terminology accuracy is binary: either ingredient names, regulatory classifications, and claim language match requirements exactly, or the submission fails.

Core Terminology Categories for Regulatory Compliance

Regulatory termbases must extend beyond simple source/target pairs to include compliance metadata, usage restrictions, and market-specific variations. The following categories represent essential terminology infrastructure for dermocosmetics localization.

1. Ingredient Nomenclature (INCI System)

The International Nomenclature of Cosmetic Ingredients (INCI) provides standardized naming that must remain consistent across all documentation. Terminology systems must link INCI names to CAS numbers, EC numbers, and common chemical names while flagging regulatory status.

Critical: INCI Name Consistency

Never use chemical names, trade names, or colloquial equivalents in regulatory submissions. “Vitamin E” in a PIF where the ingredient list shows “Tocopherol” creates automatic compliance failures. Terminology systems must enforce INCI nomenclature consistently across all document types.

2. Regulatory Classification Terms

EU Regulation 1223/2009 establishes specific classifications that require precise terminology. Mistranslating or misapplying these terms creates immediate compliance issues.

3. Claim Substantiation Terminology

Product claims must align precisely with substantiation evidence tiers. Terminology systems must categorize claims by regulatory risk and evidence requirements.

Prohibited: Medicinal/Therapeutic Claims

Never use in cosmetics documentation: treat, cure, prevent, heal, restore, repair (biological function), regenerate, therapy, therapeutic, medicine, drug, disease, disorder, condition, syndrome, remedy, prescription, clinical treatment

These terms trigger drug classification requiring pharmaceutical regulatory pathways.

4. Technical and Process Terminology

Building Regulatory Termbase Architecture

Traditional glossaries fail for regulatory localization because they treat terms as isolated translation pairs. Effective regulatory termbases model relationships between ingredients, classifications, restrictions, and market requirements.

Essential Termbase Fields

Core Identification

• Source term (EN master)
• Target equivalents (all languages)
• Part of speech
• Domain category
• Synonyms and variants

Regulatory Metadata

• INCI nomenclature (if ingredient)
• CAS/EC numbers
• Annex classification
• Concentration restrictions
• Usage conditions
• Prohibited contexts

Market Variations

• EU approved term
• FDA equivalent (if different)
• China NMPA nomenclature
• Japan MHLW variant
• Other regional differences

Usage Controls

• Approved document types
• Mandatory vs. optional
• Context dependencies
• Do not use flags
• Quality assurance rules

Knowledge Graph Architecture for Terminology

Knowledge graphs represent the next evolution in regulatory terminology management, modeling complex relationships between ingredients, regulatory classifications, market requirements, and claim substantiation hierarchies.

What is a Knowledge Graph for Terminology?

Unlike flat databases with rows and columns, knowledge graphs store terminology as interconnected nodes and relationships. An ingredient node connects to its CAS number, regulatory status, maximum concentrations, approved markets, claim restrictions, and prohibited combinations—all queryable as a unified system.

Knowledge Graph Advantages

Relationship Preservation

• Ingredient → Annex classification
• Claim → Required substantiation
• Restriction → Product category
• Term → Market-specific variant

Automated Validation

• Flag Annex violations instantly
• Detect claim over-reach
• Verify concentration compliance
• Check prohibited combinations

Context-Aware Translation

• Different terms per document type
• Market-specific nomenclature
• Product category dependencies
• Regulatory framework alignment

Scalability

• Add new markets without restructuring
• Update regulations system-wide
• Integrate new ingredient approvals
• Expand claim hierarchies

Market-Specific Terminology Variations

Regulatory terminology varies significantly across major markets. Terminology systems must account for these differences to ensure compliance in each jurisdiction.

EU vs. FDA vs. China NMPA Terminology Comparison

Critical: Do Not Auto-Translate Regulatory Terms

Terms like “cosmetic product” have specific legal definitions that differ by jurisdiction. Direct translation without regulatory context creates compliance failures. Always use jurisdiction-specific approved terminology rather than literal translations.

Pre-Submission Terminology Validation Checklist

Complete Before Regulatory Submission:

• All ingredient names match CosIng database exactly (EU) or appropriate national database
• INCI nomenclature is identical across PIF, CPNP, ingredient list, and label
• No chemical names, trade names, or common names used in place of INCI names
• Concentration values use correct decimal separators for target market (period vs comma)
• Measurement units are consistent (%, ppm, w/w) throughout documentation
• Annex classifications are accurately translated with market-specific terminology
• Claim language aligns with substantiation evidence tier
• No medicinal/therapeutic terms appear in cosmetics documentation
• Market-specific terminology variants applied correctly (EU vs FDA vs NMPA)
• Regulatory classifications use exact official terminology (not paraphrased)
• Cross-references between documents use identical terminology
• Prohibited terminology blacklist checked against all claim language